Chronic myelogenous leukemia in a child following treatment for bilateral retinoblastoma.

Abstract

A 3-year-old child was incidentally found to have chronic myelogenous leukemia (CML) during an admission for a routine ophthalmic examination under anesthesia. The child had received systemic chemotherapy and focal treatment for Groups C and D retinoblastoma in the right and left eye, respectively, when she was 7 months old. CML was treated with dasatinib, and the child attained a major molecular response. The child is now 3 years after treatment of CML, and the retinoblastoma remains inactive. CML following treatment of retinoblastoma is a rare occurrence. Long term and close monitoring of retinoblastoma patients who received systemic chemotherapy using serial blood tests is essential.

• Authors: Haitham Hilal Al-Mahrouqi, Anuradha Ganesh, Abdulhakim Al-Rawas, Vikas Khetan, Sana Al-Zuhaibi
• Journal: Oman journal of ophthalmology (Oman J Ophthalmol) 2021 Sep-Dec Vol. 14 Issue 3 Pg. 187-189 ISSN: 0974-620X [Print] India
• PMID: 34880582 (Publication Type: Case Reports)
• Copyright: Copyright: © 2021 Oman Ophthalmic Society.